A research team led by Dr. Y.H. Huang (Taipei Veterans General Hospital) and Dr. P.C. Lee (NYCU) has discovered a significant link between gut microbiome metabolites and the efficacy of immunotherapy for Hepatocellular Carcinoma (HCC).
